Data / Form D filings / Theraclion
Theraclion: Form D filing
Theraclion, a biotechnology company in Malakoff, France, filed a Form D with the SEC in 2015. The latest, on July 1, 2015, reports $250,000 sold of a $250,000 offering to 1 investor.
Find out what Theraclion does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 102, RUE ETIENNE DOLET, Malakoff, France, 92240
- Phone
- 011 33 1 5548 9070
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- France
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1646900
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1, 2015 | New notice | $250,000 | $250,000 | $0 | 1 | Jun 19, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michel Nuta | Executive Officer | |
| Bern Von Polheim | Director | |
| Sarah Ankri | Executive Officer | |
| Laurent Levy | Director | |
| Sylvain Yon | Executive Officer | |
| Francois LaCoste | Director | |
| Anja Kleber | Executive Officer | |
| Jean-Yves Burel | Director | |
| David Caumartin | Executive Officer | |
| Phillippe Pouletty | Director | |
| Vincent Gardes | Director |
Every Form D from the week of Jun 29, 2015 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Theraclion reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.